EVADO LAUNCHES SAFE CHEAP CLINICAL TRIALS SOFTWARE
May 22nd 2008 01:05
Tuesday May 20, 2008
Daily news on ASX-listed biotechnology companies
* ASX, BIOTECHS DOWN: STARPHARMA UP 9%; TISSUE THERAPIES DOWN 14%
* EVADO LAUNCHES SAFE CHEAP CLINICAL TRIALS SOFTWARE
* LARGE STUDY BACKS ATCOR’S CENTRAL BP MEASURE
* VICTORIA: ‘FUNDING ATTRACTS RESEARCHERS, BOOSTS ECONOMY’
* EUROPEAN PATENT FOR VIRALYTICS’ ANTI-CANCER COXSACKIE VIRUS
* AGENIX APPOINTS PHILIPPINES DISTRIBUTOR
* PHOSPHAGENICS APPOINTS FRED BANTI V-P BUSINESS
THE MARKET
Ten of the Biotech Daily Top 40 stocks were up, 17 fell, six traded unchanged and seven were untraded.
Starpharma was best, up three cents or 9.38 percent to 35 cents on moderate volumes, followed by Prana up 2.5 cents or 6.49 percent to 41 cents.
Tissue Therapies led the falls down two cents or 13.79 percent to 12.5 cents on small volumes, followed by Polartechnics down 10.0 percent.
subscribe to Biotech Daily at the link above or at www.biotechdaily.com.au
EVADO
Melbourne-based Evado has launched its clinical trials software claiming it increases data accuracy by 60 percent at a vastly reduced price.
At the launch at the Centre of Health Innovation at the Alfred Hospital, Evado chief executive officer Jennie Anderson said the preclinical version of the web-based system was $14,000 rising to $35,000 depending on the nature of the clinical trial.
A poster at the launch said “Evado has 80 percent of the data functionality of bigger systems for 20 percent of the cost”.
Evado said the launch was on “world clinical trials day” recognizing May 20, 1747 when James Lind began a controlled trial to treat scurvy.
The company said the web-based system could be operated from a personal computer, lap-top or computer tablet.
Ms Anderson said that Evado was in “contract negotiations” with a major pharmaceutical company and a cancer institute on using the equipment for large scale clinical trials.
Free System Offer
Ms Anderson said her company would give away one complete software package to a not-for-profit organization engaged in serious research.
Ventracor’s chief scientific officer Dr John Woodard, said his company had bought the system last November and was using the software for trials of its left ventricular assist device and described previously having to keep “pallets of paper” for US Food and Drug Administration registration purposes.
Dr Woodard said “big American databases were big, clumsy and enormously expensive for small companies to customize”.
He said the Evado system made programming relatively easy.
“We can put pictures, traces and x-rays in the database that bigger systems can’t do. We’re a very keen supporter,” Dr Woodard said.
The software’s developer, Ross Anderson said that being web-based meant never having to worry about a back-up and told of “one big pharma” who lost a lap-top computer with 5,000 patients’ records over two years of a clinical trial.
“That doesn’t happen with us,” Mr Anderson said.
He said the Evado system can monitor and store data for global trials and for numerous trials at any one time, as well as determine which users can have access to which trial and level of patient and subject data.
“We can store two billion records,” Mr Anderson said.
He said the Evado system exceeded FDA requirements and its data was compatible and transferable to other systems.
The director of the Monash University Centre for Ethics in Medicine and Society and the Clinical Ethics Service at the Alfred Hospital Prof Paul Komesaroff said the Evado system came from the germ of an idea and the “sense among clinical researchers for the need for a more flexible and accessible collection of data”.
He said the alternatives were either prohibitively expensive systems or the arduous collection of data, particularly in clinical trials of information and the use of simple, manually operated software such as XL spreadsheets, with the high risk of data error.
He said the Evado system met the requirements of easy data handling with “safety, confidentiality as well as transparency”.
“There is a need for a seamless process to manage data in a reliable safe and transparent way. It can be tailored to different requirements from single researcher to multi-national trials and all that is for the community’s benefit.
The Evado software is supported by Microsoft’s health and human services and was developed with Intel, La Trobe University and the Victorian Government.
For more information about the software or the free system go to www.evado.com.au.
subscribe to Biotech Daily at the link above or at www.biotechdaily.com.au
| 55 |
| Vote |
Add To: 
subscribe to this blog